RDY logo

RDY Current Liabilities

Annual Current Liabilities

$1.15 B
+$104.11 M+9.96%

March 31, 2024


Summary


Performance

RDY Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Quarterly Current Liabilities

$1.54 B
-$6.34 M-0.41%

December 31, 2024


Summary


Performance

RDY Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

RDY Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.0%+21.5%
3 y3 years+1.3%+21.5%
5 y5 years+33.7%+70.1%

RDY Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.3%+10.0%-0.4%+56.6%
5 y5-year-7.3%+33.7%-0.4%+70.1%
alltimeall time-12.3%+2276.5%-0.4%+3154.5%

Dr Reddys Laboratories Limited Current Liabilities History

DateAnnualQuarterly
Dec 2024
-
$1.54 B(-0.4%)
Sep 2024
-
$1.54 B(+22.0%)
Jun 2024
-
$1.27 B(+10.0%)
Mar 2024
$1.15 B(+10.0%)
$1.15 B(+2.7%)
Dec 2023
-
$1.12 B(+10.8%)
Sep 2023
-
$1.01 B(+2.8%)
Jun 2023
-
$984.07 M(-5.9%)
Mar 2023
$1.05 B(-15.7%)
$1.05 B(+2.5%)
Dec 2022
-
$1.02 B(+3.8%)
Sep 2022
-
$982.22 M(-14.6%)
Jun 2022
-
$1.15 B(-7.2%)
Mar 2022
$1.24 B(+9.2%)
$1.24 B(+10.3%)
Dec 2021
-
$1.12 B(-2.8%)
Sep 2021
-
$1.16 B(-6.2%)
Jun 2021
-
$1.23 B(+8.5%)
Mar 2021
$1.14 B(+17.6%)
$1.14 B(+12.9%)
Dec 2020
-
$1.01 B(-5.2%)
Sep 2020
-
$1.06 B(+0.6%)
Jun 2020
-
$1.05 B(+9.2%)
Mar 2020
$965.44 M(+12.3%)
$965.44 M(+6.8%)
Dec 2019
-
$904.10 M(+4.2%)
Sep 2019
-
$867.54 M(-1.3%)
Jun 2019
-
$879.39 M(+2.3%)
Mar 2019
$859.62 M(-19.7%)
$859.62 M(-3.9%)
Dec 2018
-
$894.42 M(-9.0%)
Sep 2018
-
$983.24 M(-3.7%)
Jun 2018
-
$1.02 B(-4.6%)
Mar 2018
$1.07 B(-18.3%)
$1.07 B(-6.6%)
Dec 2017
-
$1.15 B(+6.5%)
Sep 2017
-
$1.08 B(+6.5%)
Jun 2017
-
$1.01 B(-22.9%)
Mar 2017
$1.31 B(+34.6%)
$1.31 B(-6.5%)
Dec 2016
-
$1.40 B(+4.8%)
Sep 2016
-
$1.34 B(+34.3%)
Jun 2016
-
$996.71 M(+2.4%)
Mar 2016
$973.57 M(-4.9%)
$973.57 M(+2.3%)
Dec 2015
-
$951.60 M(-4.2%)
Sep 2015
-
$993.50 M(-2.0%)
Jun 2015
-
$1.01 B(-0.9%)
Mar 2015
$1.02 B(+13.3%)
$1.02 B(+11.0%)
Dec 2014
-
$922.25 M(+3.8%)
Sep 2014
-
$888.86 M(+0.8%)
Jun 2014
-
$881.50 M(-2.4%)
Mar 2014
$903.39 M(-9.1%)
$903.39 M(-1.3%)
Dec 2013
-
$915.09 M(+4.7%)
Sep 2013
-
$874.16 M(-11.6%)
Jun 2013
-
$988.99 M(-0.5%)
Mar 2013
$994.19 M
$994.19 M(+9.5%)
DateAnnualQuarterly
Dec 2012
-
$908.33 M(+1.3%)
Sep 2012
-
$896.43 M(+7.5%)
Jun 2012
-
$834.24 M(-1.4%)
Mar 2012
$846.17 M(-7.9%)
$846.17 M(-13.0%)
Dec 2011
-
$972.60 M(-7.7%)
Sep 2011
-
$1.05 B(+15.5%)
Jun 2011
-
$912.21 M(-0.7%)
Mar 2011
$918.74 M(+42.0%)
$918.74 M(+24.7%)
Dec 2010
-
$736.84 M(-0.1%)
Sep 2010
-
$737.77 M(+14.4%)
Jun 2010
-
$644.95 M(-0.3%)
Mar 2010
$646.90 M(+23.5%)
$646.90 M(+37.0%)
Dec 2009
-
$472.22 M(-6.0%)
Sep 2009
-
$502.10 M(+248.9%)
Jun 2009
-
$143.92 M(-72.5%)
Mar 2009
$523.89 M(+7.2%)
$523.89 M(-11.0%)
Dec 2008
-
$588.84 M(-4.6%)
Sep 2008
-
$617.21 M(+14.2%)
Jun 2008
-
$540.41 M(+10.6%)
Mar 2008
$488.65 M(+13.2%)
$488.65 M(+9.5%)
Dec 2007
-
$446.46 M(+4.0%)
Sep 2007
-
$429.38 M(+15.0%)
Jun 2007
-
$373.51 M(-13.5%)
Mar 2007
$431.59 M(+2.3%)
$431.59 M(-20.9%)
Dec 2006
-
$545.88 M(-7.3%)
Sep 2006
-
$588.78 M(+9.4%)
Jun 2006
-
$538.13 M(+27.5%)
Mar 2006
$422.06 M(+142.8%)
$422.06 M(+101.9%)
Dec 2005
-
$209.03 M(+0.9%)
Sep 2005
-
$207.07 M(+2.5%)
Jun 2005
-
$201.99 M(+16.2%)
Mar 2005
$173.86 M(+64.7%)
$173.86 M(+33.2%)
Dec 2004
-
$130.57 M(+4.0%)
Sep 2004
-
$125.50 M(-18.6%)
Jun 2004
-
$154.23 M(+46.1%)
Mar 2004
$105.59 M(+65.0%)
$105.59 M(+28.1%)
Dec 2003
-
$82.42 M(-1.7%)
Sep 2003
-
$83.86 M(+10.4%)
Jun 2003
-
$75.98 M(+18.8%)
Mar 2003
$63.98 M(+32.3%)
$63.98 M(+12.7%)
Dec 2002
-
$56.75 M(+6.0%)
Sep 2002
-
$53.52 M(-8.2%)
Jun 2002
-
$58.33 M(+20.6%)
Mar 2002
$48.38 M(-50.3%)
$48.38 M(+2.4%)
Dec 2001
-
$47.26 M(-6.3%)
Sep 2001
-
$50.44 M(-16.0%)
Jun 2001
-
$60.05 M
Mar 2001
$97.26 M
-

FAQ

  • What is Dr Reddys Laboratories Limited annual total current liabilities?
  • What is the all time high annual current liabilities for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited annual current liabilities year-on-year change?
  • What is Dr Reddys Laboratories Limited quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited quarterly current liabilities year-on-year change?

What is Dr Reddys Laboratories Limited annual total current liabilities?

The current annual current liabilities of RDY is $1.15 B

What is the all time high annual current liabilities for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high annual total current liabilities is $1.31 B

What is Dr Reddys Laboratories Limited annual current liabilities year-on-year change?

Over the past year, RDY annual total current liabilities has changed by +$104.11 M (+9.96%)

What is Dr Reddys Laboratories Limited quarterly total current liabilities?

The current quarterly current liabilities of RDY is $1.54 B

What is the all time high quarterly current liabilities for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high quarterly total current liabilities is $1.54 B

What is Dr Reddys Laboratories Limited quarterly current liabilities year-on-year change?

Over the past year, RDY quarterly total current liabilities has changed by +$271.86 M (+21.47%)